Clinical utility and patient adherence with ebastine for allergic rhinitis

References

• BousquetJvan de CauwenbergePAllergic Rhinitis and its Impact on Asthma (ARIA) WHO position paperJ Allergy Clin Immunol2001108S147S33411707753
   PubMed Web of Science ®Google Scholar
• BjorkstenBBrunekreefBCooksonWOvon MutiusEStrachanDPPhase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): Rationale and methodsEur Respir J20042440641215358699
   PubMed Web of Science ®Google Scholar
• BugianiACarossoAMiglioreEAllergic rhinitis and asthma comorbidity in a survey of young adults in ItalyAllergy20056016517015647036
   PubMed Web of Science ®Google Scholar
• TurkeltaubPCPrevalence of upper and lower respiratory conditions in the US population by social and environmental factors: Data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II)Ann Allergy1991671471541867453
   PubMedGoogle Scholar
• MeltzerEOQuality of life in adults and children with allergic rhinitisJ Allergy Clin Immunol2001108S45S5311449206
   PubMed Web of Science ®Google Scholar
• SchoenwetterWFDupclayLJrAppajosyulaSBottemanMFPashosCLEconomic impact and quality-of-life burden of allergic rhinitisCurr Med Res Opin20042030531715025839
   PubMed Web of Science ®Google Scholar
• TripathiAPattersonRImpact of allergic rhinitis treatment on quality of lifePharmacoeconomics20011989189911700776
   PubMed Web of Science ®Google Scholar
• PawankarRYamagishiSTakizawaRYagiTMast cell-IgE-and mast cell-structural cell interactions in allergic airway diseaseCurr Drug Targets Inflamm Allergy2003230331214561149
   PubMedGoogle Scholar
• Allergy and allergic diseasesN Engl J Med200134410911311150362
   PubMed Web of Science ®Google Scholar
• CiprandiGVizzaccaroACirilloIToscaMMassoloAPassalacquaGNasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitisInt Arch Allergy Immunol200513626627215722636
   PubMed Web of Science ®Google Scholar
• RomagnaniSThe Th1/Th2 paradigmImmunol Today1997182632669190109
   PubMedGoogle Scholar
• RomagnaniSThe role of lymphocytes in allergic diseaseJ Allergy Clin Immunol200010539940810719286
   PubMed Web of Science ®Google Scholar
• RomagnaniSRegulatory T cells: Which role in the pathogenesis and treatment of allergic disorders?Allergy20066131416364151
   PubMed Web of Science ®Google Scholar
• TaylorAVerhagenJAkdisCAAkdisMT regulatory cells in allergy and health: A question of allergen specificity and balanceInt Arch Allergy Immunol2004135738215340251
   PubMed Web of Science ®Google Scholar
• CiprandiGBuscagliaSPesceGPMinimal persistent inflammation is present at mucosal level in asymptomatic rhinitic patients with allergy due to mitesJ Allergy Clin Immunol1995969719978543756
   PubMed Web of Science ®Google Scholar
• CustovicAvan WjikGThe effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN)Allergy2005601112111516076293
   PubMed Web of Science ®Google Scholar
• SimonsFERAdvances in H1-antihistaminesN Engl J Med20043512203221715548781
   PubMed Web of Science ®Google Scholar
• CiprandiGRiccaVToscaMContinuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergyAllergy19995435836510371095
   PubMed Web of Science ®Google Scholar
• PassalacquaGAlbanoMCanonicaGWInhaled and nasal corticosteroids: Safety aspectsAllergy200055163310696853
   PubMed Web of Science ®Google Scholar
• LockeyRFNikoara-KastiGLTheodoropoulosDSBukantzSCSystemic reactions and fatalities associated with allergen immunotherapyAnn Allergy Asthma Immunol200187S46S55
   Web of Science ®Google Scholar
• CoxLLarenasDNolteHWeldonDFinegoldISublingual immunotherapy: A comprehensive reviewJ Allergy Clin Immunol20061171021103516675328
   PubMed Web of Science ®Google Scholar
• World Health Organization Position PaperAllergen immunotherapy: Therapeutic vaccines for allergic diseasesBousquetJLockeyRMallingHJAllergy199853313
   Web of Science ®Google Scholar
• MallingHJAbreu-NogueraJAlvarez-CuestaELocal immunotherapy: Position paperAllergy1998538338449788683
   PubMed Web of Science ®Google Scholar
• MollerCDreborgSFerdousiHAPollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT study)J Allergy Clin Immunol200210925125611842293
   PubMed Web of Science ®Google Scholar
• NovembreEGalliELandiFCoseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitisJ Allergy Clin Immunol200411485115480326
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to long-term therapies: Evidence for actionGenevaWorld Health Organization2003
   Google Scholar
• BousquetJReidJvan WeelCAllergic rhinitis management pocket reference 2008Allergy20086399099618691301
   PubMed Web of Science ®Google Scholar
• RobertsDJA preclinical overview of ebastineDrugs1996528148828021
   PubMed Web of Science ®Google Scholar
• VincentJLiminanaRMeredithPAReidJLThe pharmacokinetics, antithistamine and concentration-effect relationship of ebastine in healthy subjectsBr J Clin Pharmacol1988264975022905150
   PubMed Web of Science ®Google Scholar
• SastreJEbastine in allergic rhinitis and chronic urticariaAllergy20086312019032340
   PubMed Web of Science ®Google Scholar
• AnkierSIWarringtonSJA double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hayfever in general practiceJ Intern Med19892264534582577377
   PubMed Web of Science ®Google Scholar
• de MolinaMCadahiaACanoLSanzAEfficacy and tolerability of ebastine at two dose levels in the treatment of seasonal allergic rhinitisDrug Invest198914046
   Google Scholar
• PelaezAClinical efficacy of ebastine in the treatment and prevention of seasonal allergic rhinitisDrugs19965235388828025
   PubMed Web of Science ®Google Scholar
• StormsWWClinical studies of the efficacy and tolerability of ebastine 10 mg or 20 mg once daily in the treatment of seasonal allergic rhinitis in the USDrugs19965220258828022
   PubMed Web of Science ®Google Scholar
• GehannoPBremard-OuryCZeisserPComparison of ebastine cetirizine in seasonal allergic rhintis in adultsAnn Allergy Asthma Immunol1996765075128673684
   PubMed Web of Science ®Google Scholar
• HampelFHowlandWvan BavelJRatnerPA randomized double-blind placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitisJ Investig Allergol Clin Immunol2004145663
   PubMed Web of Science ®Google Scholar
• RatnerPHampelFvan BavelJHowlandWEfficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: A randomized double-blind placebo-controlled studyInt Arch Allergy Immunol200413337137915031611
   PubMed Web of Science ®Google Scholar
• RatnerPHLimJCGeorgesGCEbastine Study GroupComparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitisJ Allergy Clin Immunol20001051101110710856142
   PubMed Web of Science ®Google Scholar
• RatnerPFalquesMChuecosFEsbriRGispertJPerisFMeta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitisInt Arch Allergy Immunol200513831231816224195
   PubMed Web of Science ®Google Scholar
• CiprandiGCirilloIMoraFLa RosaMEbastine improves nasal symptoms and airflow and affects response to decongestion test in patient with persistent allergic rhinitisAllergy Asthma Proc20072857858117883885
   PubMed Web of Science ®Google Scholar
• BousquetJGaudanoEMPalma CarlosAGStaudingerHA 12-week placebo-controlled study of the efficacy and safety of ebastine 10 and 20 mg once daily in the treatment of perennial allergic rhinitisAllergy19995456256810435469
   PubMed Web of Science ®Google Scholar
• Picado-VallesCCadahia-GarciaABahimaCEbastine in perennial allergic rhinitisAnn Allergy1991676156181684273
   PubMedGoogle Scholar
• DaviesRJEuropean Multicentre Study GroupEfficacy and tolerability comparison of ebastine 10 and 10 mg with loratadine 10 mgClin Drug Invest199816413420
   PubMed Web of Science ®Google Scholar
• Murris-EspinMMelacMCharpentierJCDidierAComparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitisAnn Allergy Asthma Immunol1998803994039609610
   PubMed Web of Science ®Google Scholar
• KalisBDouble-blind multicenter comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adultsDrugs19965230348828024
   PubMed Web of Science ®Google Scholar
• MossAJChaikinPGarciaJDGillenMRobertsDJMorganrothJA review of the cardiac systemic side-effects of antihistamines: EbastineClin Exp Allergy19992920020510444238
   PubMed Web of Science ®Google Scholar
• HindmarchIShamziZAntihistamines: Models to assess sedative properties, assessment of sedation, safety and other side-effectsClin Exp Allergy19992913314210444227
   PubMed Web of Science ®Google Scholar
• SalvàMCarrenoBPintosMJansatJMRosalesMJMegardYPhase I, single dose, open-label, randomized, cross-over bio-equivalence studies of ebastine 10 mg and 20 mg fast-dissolving tablets in healthy male volunteersJ Invest Allergol Clin Immunol200414S5
   Google Scholar
• RogerAForteaJMoraSArtesMPatient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitisExpert Rev Pharmacoecon Outcomes Res2008833734220528340
   PubMedGoogle Scholar
• RogerAForteaJMoraSArtesMEbasstine fast-dissolving tablets versus regular tablets: Acceptability and preference in patients with allergic rhinitisExpert Rev Clin Pharmacol20081381389
   PubMedGoogle Scholar
• RogerAForteaJPlazasMJMoraSArtesMAssessment of patient satisfaction with ebastine fast-dissolving tablets in patients suffering from allergic rhinitisTherapy20096407415
   Google Scholar
• CiprandiGCirilloIPistorioAdi GioacchinoMFenoglioDEbastine increases IFN-gamma in patients with persistent allergic rhinitisJ Bio Regul Homeost Agents200923313619321044
   PubMed Web of Science ®Google Scholar
• BousquetJvan CauwenbergePBachertCCanonicaGWDemolyPDurhamRRequirement for medications commonly used in the treatment of allergic rhinitisAllergy20035819219712653792
   PubMed Web of Science ®Google Scholar